Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |